Sulphakream-N Vaginal Cream 15% 80G

Name: Sulphakream-N Vaginal Cream 15% 80G
Brand: NABIQASIM INDUSTRIES
Price: 186.69

Brand : nabiqasim industries

Rs. 186.69

Rs. 196.52

|

QUICK DELIVERY

Sulphakream-N Vaginal Specification

Requires Prescription (YES/NO)

Yes

Generics

Sulphanilamide

Used For

Vaginal Care

How it works

Sulfanilamide has been a useful ingredient of vaginal formulations for about four decades. It blocks certain metabolic processes essential for the growth of susceptible bacteria. In this, the sulfanilamide is in a specially compounded base buffered to the pH (about 4.3) of the normal vagina to encourage the presence of the normally occurring Döderlein’s bacilli of the vagina.

Sulphakream-N Vaginal Usage And Safety

Dosage

Sulphanilamide

Side Effects

Local sensitivity reactions such as increased discomfort or a burning sensation have occasionally been reported following the use of topical sulfonamides .

Drug Interactions

Drug interactions have not been documented . Ask your physician or pharmacist for any drug interaction.

Indication

For the treatment of vulvovaginitis caused by Candida albicans .

When not to Use

It should not be used in patients known to be sensitive to this product or to the sulfonamides.

Sulphakream-N Vaginal Precautions

Precaution

Because sulfonamides are absorbed from the vaginal mucosa, the usual precautions for oral sulfonamides apply. Patients should be observed for skin rash or evidence of systemic toxicity, and if these develop, the medications should be discontinued .

Sulphakream-N Vaginal Warnings

Warning 1

Deaths associated with administration of oral sulfonamides have reportedly occurred from hypersensitivity reactions, agranulocytosis, aplastic anemia, and other blood dyscrasias.

Warning 2

Goiter production, diuresis, and hypoglycemia have reportedly occurred rarely in patients receiving oral sulfonamides. Cross-sensitivity may exist with these agents. Rats appear to be especially susceptible to the goitrogenic effects of sulfonamides, and long-term administration has reportedly produced thyroid malignancies in this species.

Warning 3

The doctor should advise the patient that in the event unusual local itching and burning occur, or other unusual symptoms develop, medication should be discontinued and not restarted without further consultation .

Download the Dvago App